文献速递基础与转化研究临床试验与 GCP流行病学与生物统计

五羟色胺转运体基因(SLC6A4)多态性与南非社区健康工作者家访母婴依恋干预易感性:一项随机对照试验的再分析

Serotonin transporter gene (SLC6A4) polymorphism and susceptibility to a home-visiting maternal-infant attachment intervention delivered by community health workers in South Africa: Reanalysis of a randomized controlled trial.
PubMed 文献 · PLoS Med · 2017-02-28

本研究再分析南非Khayelitsha地区一项由社区健康工作者实施的家访母婴依恋干预随机对照试验,干预从妊娠晚期至产后6个月共16次家访,220对母婴接受干预,229对对照。18月龄时干预组安全依恋显著高于对照组(OR=1.7,p=0.029,95%CI 1.06-2.76,d=0.29)。对220名有基因型和依恋数据的儿童分析显示,携带至少一个短等位基因者干预效应更大(OR=3.86,p=0.008,95%CI 1.42-10.51,d=0.75),而仅携带长等位基因者效应微弱(OR=0.95,p=0.89,95%CI 0.45-2.01,d=0.03)。

要点

  • 家访母婴依恋干预总体效应量为d=0.29(OR=1.7,95%CI 1.06-2.76)。
  • 携带至少一个短等位基因者干预效应d=0.75(OR=3.86,95%CI 1.42-10.51)。
  • 仅携带两个长等位基因者干预效应d=0.03(OR=0.95,95%CI 0.45-2.01)。

核心结论

  • 考虑五羟色胺转运体多态性后,针对贫困孕妇的母婴依恋干预效应量在仅携带短等位基因者中增加超过2.5倍(从d=0.29增至d=0.75),在仅携带两个长等位基因者中降低10倍(从d=0.29降至d=0.03)。
  • 遗传差异易感性意味着对所有参与者取平均是误导性的疗效指标。
  • 研究提出政策制定者在实施心理社会干预时如何平衡公平(所有人平等治疗)与疗效(仅治疗基因上可能受益者)的挑战。

研究设计与样本

  • 对一项在南非Khayelitsha黑人isiXhosa语人群中由社区健康工作者实施的家访项目随机对照试验进行再分析。
  • 干预于1999年4月至2003年2月实施,从妊娠晚期至产后6个月,由专门培训的社区健康工作者提供16次家访,干预组220对母婴,对照组229对母婴未接受干预。
  • 主要结局为婴儿18月龄时母婴依恋安全性。
  • 试验后,162名干预组和172名对照组儿童在13岁时(2012年12月至2014年6月)重新入组随访研究。
  • 从279名儿童(134名干预组和145名对照组)采集DNA进行五羟色胺转运体常见多态性基因分型。

主要发现

  • 与对照组相比,干预组婴儿与主要照护者形成安全依恋的可能性显著更高(OR=1.7,p=0.029,95%CI 1.06-2.76,d=0.29)。
  • 在220名个体中,携带至少一个短等位基因者干预组相对对照组安全依恋率高出26%(OR=3.86,p=0.008,95%CI 1.42-10.51,d=0.75)。
  • 仅携带长等位基因者干预组与对照组安全依恋差异为1%(OR=0.95,p=0.89,95%CI 0.45-2.01,d=0.03)。
  • 以绝对风险表示,短等位基因携带者中干预组安全依恋概率为84%(95%CI 73%-95%),对照组为58%(95%CI 43%-72%);两个长等位基因拷贝者中干预组为70%(95%CI 59%-81%),对照组为71%(95%CI 60%-82%)。
  • 控制性别、母亲基因型和社会经济逆境指数(住房、就业、教育、电力、水)后这些结果未改变。

局限性

  • 本研究仅能重新入组原随机样本中49%的干预组和对照组参与者。
  • 在当前子样本中将主要结局归因于干预的因果效应应谨慎对待。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clear recognition of the damaging effects of poverty on early childhood development has fueled an interest in interventions aimed at mitigating these harmful consequences. Psychosocial interventions aimed at alleviating the negative impacts of poverty on children are frequently shown to be of benefit, but effect sizes are typically small to moderate. However, averaging outcomes over an entire sample, as is typically done, could underestimate efficacy because weaker effects on less susceptible individuals would dilute estimation of effects on those more disposed to respond. This study investigates whether a genetic polymorphism of the serotonin transporter gene moderates susceptibility to a psychosocial intervention. METHODS AND FINDINGS: We reanalyzed data from a randomized controlled trial of a home-visiting program delivered by community health workers in a black, isiXhosa-speaking population in Khayelitsha, South Africa. The intervention, designed to enhance maternal-infant attachment, began in the third trimester and continued until 6 mo postpartum. Implemented between April 1999 and February 2003, the intervention comprised 16 home visits delivered to 220 mother-infant dyads by specially trained community health workers. A control group of 229 mother-infant dyads did not receive the intervention. Security of maternal-infant attachment was the main outcome measured at infant age 18 mo. Compared to controls, infants in the intervention group were significantly more likely to be securely attached to their primary caregiver (odds ratio [OR] = 1.7, p = 0.029, 95% CI [1.06, 2.76], d = 0.29). After the trial, 162 intervention and 172 control group children were reenrolled in a follow-up study at 13 y of age (December 2012-June 2014). At this time, DNA collected from 279 children (134 intervention and 145 control) was genotyped for a common serotonin transporter polymorphism. There were both genetic data and attachment security data for 220 children (110 intervention and 110 control), of whom 40% (44 intervention and 45 control) carried at least one short allele of the serotonin transporter gene. For these 220 individuals, carrying at least one short allele of the serotonin transporter gene was associated with a 26% higher rate of attachment security relative to controls (OR = 3.86, p = 0.008, 95% CI [1.42, 10.51], d = 0.75), whereas there was a negligible (1%) difference in security between intervention and control group individuals carrying only the long allele (OR = 0.95, p = 0.89, 95% CI [0.45, 2.01], d = 0.03). Expressed in terms of absolute risk, for those with the short allele, the probability of secure attachment being observed in the intervention group was 84% (95% CI [73%, 95%]), compared to 58% (95% CI [43%, 72%]) in the control group. For those with two copies of the long allele, 70% (95% CI [59%, 81%]) were secure in the intervention group, compared to 71% (95% CI [60%, 82%]) of infants in the control group. Controlling for sex, maternal genotype, and indices of socioeconomic adversity (housing, employment, education, electricity, water) did not change these results. A limitation of this study is that we were only able to reenroll 49% of the original sample randomized to the intervention and control conditions. Attribution of the primary outcome to causal effects of intervention in the present subsample should therefore be treated with caution. CONCLUSIONS: When infant genotype for serotonin transporter polymorphism was taken into account, the effect size of a maternal-infant attachment intervention targeting impoverished pregnant women increased more than 2.5-fold when only short allele carriers were considered (from d = 0.29 for all individuals irrespective of genotype to d = 0.75) and decreased 10-fold when only those carrying two copies of the long allele were considered (from d = 0.29 for all individuals to d = 0.03). Genetic differential susceptibility means that averaging across all participants is a misleading index of efficacy. The study raises questions about how policy-makers deal with the challenge of balancing equity (equal treatment for all) and efficacy (treating only those whose genes render them likely to benefit) when implementing psychosocial interventions. TRIAL REGISTRATION: Current Controlled Trials ISRCTN25664149.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Morgan B, Kumsta R, Fearon P, et al. Serotonin transporter gene (SLC6A4) polymorphism and susceptibility to a home-visiting maternal-infant attachment intervention delivered by community health workers in South Africa: Reanalysis of a randomized controlled trial. PLoS Med. 2017. PMID: 28245280. doi:10.1371/journal.pmed.1002237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。